Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Status of nuclear medicine in Beijing: insights from the Beijing Quality Control Centre Survey 2005–2006

Hongwei, Sia; Jianhua, Gengb; Shengzu, Chenb

Nuclear Medicine Communications: March 2008 - Volume 29 - Issue 3 - p 298-302
doi: 10.1097/MNM.0b013e3282f38f54

Objective To evaluate the status of nuclear medicine in Beijing during 2005.

Methods For evaluating the status, a survey was performed in September 2006 by postal questionnaires. Forty-two nuclear medicine departments in Beijing were investigated regarding staff, equipment and clinical applications.

Results Up to January 2007, thirty nuclear medicine departments had responded to our survey (response rate, 71.4%). These departments employed a total of 321 staff (141 physicians, 122 technicians, seven physicists, 22 nurses and 29 other staff) and were equipped with 47 scanners (42 SPECT, three PET, two PET/CT) before September 2006. During 2005, these departments completed 88 135 scans (84 734 SPECT, 3401 PET), 462 246 radioimmunoassays and 2228 radioisotope treatment (1288 Graves' disease, 268 thyroid cancer, 166 bone metastasis, 506 other). Furthermore, eight major hospitals hired more highly qualified staff with greater experience, such as professors or associate professors, and who had more clinical applications than did non-majors. The percentage of the departments that conducted daily and monthly quality control procedures was 43.3% and 40.0%, respectively.

Conclusion Nuclear medicine departments in Beijing are on a considerable scale, but still have a long way to go in order to be well developed. Hospitals in Beijing should increase the number of physicists and performed QA/QC procedures more frequently.

aDepartment of Nuclear Medicine, 1st Affiliated Hospital of Anhui, Medical University, Hefei, Anhui Province, 230022, China

bDepartment of Nuclear Medicine, Cancer Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing

Correspondence to Professor Chen Shengzu, Department of Nuclear Medicine, Cancer Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100021, China

Tel: +86 (0)1322 5850069; fax: +86 10 67713359; e-mail:

Received 20 December 2006 Revised 8 September 2007 Accepted 9 October 2007

© 2008 Lippincott Williams & Wilkins, Inc.